Get ready for a newer innovative way to appear smoother without fine lines.
Introducing DAXXIFY™ – the only long-lasting, peptide-powered frown line treatment and the first innovation of its kind in over 20 years.
At its core, DAXXIFY™ is an injectable, anti-wrinkle treatment system that helps target dynamic wrinkles on a patient’s face.
Nearly 90% of patients say they wish results lasted longer. With DAXXIFY™, you can keep your frown lines smoother for a full year with as few as 2 treatments.*Current on-the-market injectables last 3 – 4 months and require up to 4 treatments a year to maintain results.
The active ingredient in many of these products is botulinum toxin A. This ingredient smooths out moderate to severe frown lines on a patient’s face. But, botulinum must also be stabilized via either HSA or other alternative proteins. DAXXIFY™ became notable immediately for being the first product of its kind to use a novel peptide as a stabilizer, meaning that it doesn’t contain byproducts from either humans or animals of any kind.
DAXXIFY™ is FDA approved to help smooth moderate to severe lines between the brows. It is the only long-lasting frown line treatment powered by a peptide with results that last on average 6 months and up to 9 months for some.
Areas of Treatment
DAXXIFY™ is a prescription medicine that is injected into muscles and used in adults to temporarily improve the look of moderate to severe frown lines between the eyebrows.
DAXXIFY™ Lasting Difference
The long lasting cosmetic dermatology frown line treatment. DAXXIFY™ extends your treatment cycle. Get more than 6 months of smoother facial lines. At its core, DAXXIFY™ is an injectable, anti-wrinkle treatment system that helps target dynamic wrinkles on a patient’s face.
Before & After
Frequently Asked Questions
What is DAXXIFY™ and how is it different?
DAXXIFY™ is FDA-approved to help smooth moderate to severe lines between the brows. It is the only long-lasting frown line treatment powered by a peptide with results that last on average 6 months and up to 9 months for some. Produced by Revance Therapeutics, Daxxify is a revolutionary new product.
How is DAXXIFY™ different from Other frown line treatments?
DAXXIFY is the only long-lasting frown line treatment powered by a peptide. Results last on average 6 months and up to 9 months for some.
• All frown line treatments require a special ingredient to stabilize botulinum toxin A, the protein responsible for helping smooth moderate to severe frown lines. For instance, BOTOX® Cosmetic uses human serum albumin (HSA), a blood product, as its stabilizer. Dysport®, another frown line treatment, uses HSA as a stabilizer and cow’s milk protein as a protectant.
• DAXXIFY is unique because it is the only formulation that uses a novel peptide as a stabilizer and does not contain human or animal byproducts.
• At least 50% of patients in clinical studies had no or minor frown lines 6 months after treatment. Between 3% and 5% of patients in clinical studies had no or minor frown lines 9 months after treatment. In other safety studies, between 5% and 17% of patients still had noticeable improvement 9 months later.
Will I need the same number of units as my current frown line treatment?
In short, no, and here’s why. Units are like fingerprints—they are a proprietary measurement of a treatment’s unique potency. Because of the differences in how treatments are formulated and tested, you cannot compare or convert Units between them, just like you cannot compare 2 fingerprints. A clearer way to understand dosing is to look at how many nanograms of active ingredient (botulinum toxin type A) a product has. Double the Units does not mean double the dose DAXXIFY™ Approved frown line dose: 40 Units Amount of active ingredient: 0.18 nanograms BOTOX® Cosmetic Approved frown line dose: 20 Units Amount of active ingredient: 0.18 nanograms DYSPORT® Approved frown line dose: 50 Units Amount of active ingredient: 0.27 nanograms As you can see, despite the number of Units, DAXXIFY™ isn’t 2x the dose of BOTOX® Cosmetic, nor is Dysport® 2.5x the dose of BOTOX® Cosmetic. Talk to your provider about DAXXIFY™ and your aesthetic goals.
How often will I need to get DAXXIFY™ and when will I See results?
DAXXIFY™ was studied in the largest-ever clinical study for a frown line treatment and included more than 2,800 people across different ages and skin types. Here are some things you should know about DAXXIFY™:
• There were no serious treatment-related side effects
• The active ingredient in DAXXIFY™ is botulinum toxin type A, an ingredient that has been used in frown line treatments for more than 20 years • 96% of people treated with DAXXIFY™ were satisfied with their results‡
• 96% of patients reported they were satisfied on a 7-point scale when evaluated at 4 weeks in clinical studies.
• The safety and efficacy of DAXXIFY™ is well established, with more than 20 years of research. In fact, DAXXIFY™ has been studied in the largest ever phase 3 clinical trial program conducted for a frown line treatment and included more than 2,400 people across different ages and with different skin types. There were no notable differences in how DAXXIFY™ performed in clinical trial patients with varying skin types.
Why are peptides important?
All frown line treatments require a special ingredient to stabilize botulinum toxin A, the protein responsible for helping smooth moderate to severe frown lines. For instance, BOTOX® Cosmetic uses human serum albumin (HSA), a blood product, as its stabilizer. Dysport®, another frown line treatment, uses HSA as a stabilizer and cow’s milk protein as a protectant. DAXXIFY™ is unique because it is the only formulation that uses a novel peptide as a stabilizer and does not contain human or animal byproducts.
Is DAXXIFY™ well studied?
DAXXIFY™ was studied in the largest-ever clinical study conducted for a frown line treatment and included more than 2,400 people across different ages and skin types.
• There were no serious treatment-related side effects in clinical trials for DAXXIFY™.
• The active ingredient in DAXXIFY™ is botulinum toxin type A, an ingredient that has been used in frown line treatments for more than 20 years. 96% of people treated with DAXXIFY™ were satisfied with their results.
• 96% of patients reported they were satisfied on a 7-point scale when evaluated at 4 weeks in clinical studies.
Request Your Consultation Today with Dr. Echavez
Relax. We know everyone’s skin is a bit different. Once our knowledgeable doctor, with years of facial plastic surgery expertise, completes your initial skin consultation and analysis he will give you the answers that are right for your face and recommend the products and services that will help you look and feel great.
